“科八条”发布以来 科创板已顺利完成并购交易110单

Group 1 - The core viewpoint of the article highlights the unprecedented vitality and activity in the M&A market of the Sci-Tech Innovation Board, driven by institutional innovation, regulatory optimization, and service system upgrades [1] - Since the release of the "Eight Measures," a total of 156 M&A transactions have been disclosed by listed companies on the Sci-Tech Innovation Board, with nearly 110 transactions successfully completed, indicating a completion rate of about 70% [1] - In 2025, the market has seen a significant increase in M&A activity, with 95 new transactions disclosed, including 29 share/convertible bond transactions and 7 major cash transactions, both showing substantial growth compared to the same period last year [1] Group 2 - Notable highlights in major asset restructuring transactions include the first registered share-based "loss-making" acquisition post-"Eight Measures" and the first comprehensive payment case utilizing shares, convertible bonds, and cash [2] - Market innovations in non-major transactions are exemplified by the use of an "Earn-out" price adjustment mechanism in a transaction by Shengxiang Biology, showcasing flexible valuation mechanisms [2] - Various companies have demonstrated the flexibility and diversity of market-oriented M&A arrangements, such as the acquisition strategies employed by Jiewate and Fuchuang Precision, which utilize acquisition loans and binding arrangements for shareholding [3]